Every investment project is a basis for development of the society and creating new values. The investor's goal is a profit maximization through investments. In order to realize the investment and make the decision, the investment project needs to be evaluated, which is done by several economic and financial evaluation criteria. Starting off with the economic and financial evaluation criteria, the calculation of the current net value, relative current net value, internal profit rate and sensitivity analysis are shown in this paper in order to show profitability and validity of making the decision about realization of investment project in pharmaceutical industry. Making correct and timely decisions about investment projects is an opportunity for development and expansion of the company, which especially applies to the pharmaceutical industry, as its business is greatly influenced by the governing bodies and agencies. Under pressure of market development and strong competition in pharmaceutical industry, managements of the companies are forced to make quick decisions in segments of business development, which is enabled through newly designed investment projects. Therefore, it is of utmost importance to assume data while planning the investment project as realistically as possible. In case of choosing and realizing the wrong investment projects, the companies can bring themselves to significant losses, resources outflow and bankruptcy. Through positive results a justification for investment projects and investments in real assets are shown, and additionally the investment project sensitivity analysis is also implemented.